Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: PHASEBIO PHARMACEUTICALS, INC
Firm Income Reported for This Client
$40K
Not substituted for client expenses
Summary
PhaseBio Pharmaceuticals, Inc. is an organization. Its political footprint includes $40K in lobbying-firm income reported for this client. Lobbying activity focuses on Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues. Political activity spans from 2020 to 2021.
Legal entity: GLEIF